Bioactivity:

VHD-valtrate has anticancer effects against human ovarian cancer cells in vitro and in vivo, it is a potential therapeutic agent for ovarian cancer, providing a basis for development of the compound as a novel chemotherapeutic agent.

CAS nr:

28325-56-6

Purity:

98%

Molecular Weight:

540,6

SMILES:

CC(C)CC(=O)OC(C(C)C)C(=O)OCC1=CO[C@@H](OC(=O)CC(C)C)C2[C@]3(CO3)[C@H](C[C@]12O)OC(C)=O

Formula:

C27H40O11

Pathway:

Proteases/Proteasome,Apoptosis,DNA Damage/DNA Repair,Chromatin/Epigenetic,Apoptosis,Apoptosis,Apoptosis

Target:

Caspase,Caspase,PARP,PARP,Mdm2,BCL,p53